Analyses of hospitalization of diabetes mellitus patients in Poland by gender, age and place of residence

• Autorzy: Gajewska M. , Gebska-Kuczerowska A. , Gorynski P. , Wysocki M. J.
• Języki publikacji: EN

Abstrakty

EN

Aim. The purpose of this study was to analyze the hospitalization of diabetes mellitus patients in Polish hospitals in 2005-2009. Materials and Methods. Data was taken from a nationwide database, kept at the National Institute of Public Health – National Institute of Hygiene in Warsaw. Data gathered for this work related to patients whose main cause of hospitalization was diabetes. Results. In the period of five years the number of diabetes-caused hospitalizations increased by nearly 22% – from 172.2 per 100 thousand in 2005 to 209.9 per 100 thousand in 2009. Hospital treatment covered mainly patients suffering from type 2 diabetes (116.4 per 100 thousand in 2009), as well as type 1 diabetes (87.6 per 100 thousand in 2009). Patients under 39 years of age were more often hospitalized because of type 1 diabetes, whereas in the older age groups patients were more often treated in hospitals for type 2 diabetes. Generally, in both types of the disease, older patients required hospitalizations more often than the younger ones. Cardiovascular diseases were the most reported co-morbidity in both types of the disease. In 2005-2009 the hospital mortality rate decreased with regard to both types of diabetes and an average length of hospital stay decreased by one day, reaching 8.1 days in 2009. Conclusion. It must be emphasized that the growing epidemic of diabetes and its complications are an important challenge to society. The percentage of people hospitalized due to diabetes is increasing every year and consumes significant resources dedicated to health care. Early diagnosis and appropriate treatment of diabetes are imperative, as well as reducing the disparities in access to medical care (ambulatory and stationary) for town and country residences.

• Wydawca: -
• Czasopismo: Annals of Agricultural and Environmental Medicine
• Rocznik: 2013
• Tom: 20
• Numer: 1
• Opis fizyczny: p.61-67,fig.,ref.

Twórcy

autor

Gajewska M.

• Department of Health Promotion and Postgraduate Education, National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland

autor

Gebska-Kuczerowska A.

• Department of Health Promotion and Postgraduate Education, National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland

autor

Gorynski P.

• Department – Centre for Monitoring and Analyses of Population Health, National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland

autor

Wysocki M. J.

• Department of Health Promotion and Postgraduate Education, National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland

Bibliografia

• 1. 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicale Diseases (2008), WHO, Geneva. 5-12.
• 2. Roglic G, Unwin N, Bennet PH, et al. The burden of mortality attributable to diabetes. Diabetes Care. 2005; 28: 2130-2135.
• 3. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27:1047-1053.
• 4. International Diabetes Federation. http://www.idf.org (access: 6.11.2010).
• 5. Greeg EW, Cadwell BL, Yrling JC, et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levelsin the U.S. Diabetes Care. 2004; 27: 2806-2812.
• 6. Dunstan DW, Zimmet PZ, Welbron TA. The rising prevalence of diabetes and impaired glucose tolerance. Diabetes Care. 2002; 25: 829-834.
• 7. Beard HA, Ghatrif MA, Samper-Ternent R, et al. Trends in diabetes prevalence and diabetes-related complications in older Mexican Americans from 1993-1994 to 2004-2005. Diabetes Care. 2009; 32:2212-2217.
• 8. Gale AM. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002; 51: 3353-3361.
• 9. The DIAMOND Project Group: Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med. 2006; 23: 857-866.
• 10. Rathmann W, Haastert B, Icks A, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficientscreening. The KORA survey 2000. Diabetol. 2003; 46: 182-189.
• 11. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and prediabetes in the U.S. population in 1988-1994 and 2005-2006. DiabetesCare. 2009; 32: 287-294.
• 12. Valdes S, Botas P, Delgado E, Diaz Cordorniga F. Mortality in Spanish adults with diagnosed diabetes, undiagnosed diabetes or pre-diabetes.The Asturias study 1998-2004. Rev Esp Cardiol. 2009; 62: 528-534.
• 13. Sosnowski C, Janeczko-Sosnowska E, Pasierski T, et al. Wpływ cukrzycy typu 2 na miażdżycę tętnic wieńcowych i obwodowych. DiabetolDoświadczalna Klin. 2005; 5: 433-438.
• 14. Heidemann C, Boening H, Pischon T, et al. Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types ofcancer and mortality: a prospective study in the European ProspectiveInvestigation into Cancer and nutrition (EPIC) – Potsdam cohort. EurJ Epidemiol. 2009; 24: 281-288.
• 15. Greeg EW, Mangione CM, Cauley JA, et al. Diabetes and incidence of functional disability in older women. Diabetes Care. 2002; 25: 61-67.
• 16. Bolin K, Gips C, Mörk AC. et al. Diabetes, health care cost and loss of productivity in Sweden 1987 and 2005 – a register-based approach.Diabetic Med. 2010; 26: 928-934.
• 17. Dall TM, Zhang Y, Chen YJ. et al. The economic burden of diabetes. Health Affairs 2010; 29: 297-313.
• 18. Kanavos P, Aardweg S, Schurer W. Diabetes expenditure, burden of disease and management in 5 EU countries. LSE Health, LondonSchool of Economics, January 2012. http://www2.lse.ac.uk/LSEHealthAndSocialCare/research/LSEHealth/MTRG/LSE_Diabetes_EXECSUM_24JAN2012.pdf
• 19. International Classification of Diseases (ICD-10). http://www.who.int/classifications/icd/en/ (access: 22.08.2010).
• 20. Wysocki KJ, Zejda JE. Epidemiologia chorób zakaźnych w Polsce w drugiej połowie dwudziestego wieku. Przegl Epidemiol. 2007; 61:615-628.
• 21. Zdrojewski T, Bandosz P, Szpakowski P, et al. Rozpowszechnienie głównych czynników ryzyka chorób układu sercowo-naczyniowego w Polsce. Wyniki badania NATPOL PLUS. Kardiol Pol. 2004; 61(Suppl. 4):1-26.
• 22. Program prewencji i leczenia cukrzycy w Polsce. http://www.mz.gov.pl/wwwfiles/ma_struktura/docs/program_cukrzyca_22102009.pdf(access: 18.06.2010).
• 23. Lee JM, Okumara MJ, Freed GL, et al. Trends in hospitalizations for diabetes among children and young adults: United States, 1993-2004.Diabetes Care. 2007; 30: 3035-3039.66
• 24. Wang J, Imai K, Engelgau MM, et al. Secular trends in diabetes-related preventable hospitalizations in the United States, 1998-2006. DiabetesCare. 2009; 32: 1213-1217.
• 25. Kim S. Burden of hospitalizations primarily due to uncontrolled iabetes. Implications of inadequate primary health care in the United States. Diabetes Care. 2007; 30: 1281-1282.
• 26. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. WHO Department of Noncommunicable Diseases Surveillance. Geneva 1999 http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf (access:21.06.2010).
• 27. Lammi N, Taskinen O, Moltchanova E, et al. A high incidence of type 1 diabetes and alarming increase in the incidence of type 2 diabetesamong young adults in Finland between 1992 and 1996. Diabetol.2007; 50: 1393-1400.
• 28. Jarosz-Chabot P, Deja G, Polanska J. Epidemiology of type 1 diabetes among Silesian children aged 0-14 years, 1989-2005. Diabetol. 2010;47: pg. 29.
• 29. Barat P, Valade A, Brosselin P, et al. The growing incidence of type 1 diabetes in children: The 17-year French experience in Aquitaine.Diabetes Metabol. 2008; 34: 601-605.
• 30. Harrison LC, Honeyman MC. Cow’s milk and type 1 diabetes. The real debate is about mucosal immune function. Diabetes. 1999; 48:1501-1508.
• 31. Graves PM, Norris JM, Pallansch MA, et al. The role of enteroviral infections in the development of IDDM. Limitations of currentapproaches. Diabetes. 1997; 46: 161-168.
• 32. Jaworska J, Kulik TB, Rudnicka-Drożak E, et al. Opieka medyczna w cukrzycy w opinii pacjentów z województwa lubelskiego. Zdr Publ.2004; 114: 515-518.
• 33. Sieradzki J, Grzeszczak W, Karnafel W, et al. Badanie PolDiab. Część I. Analiza leczenia cukrzycy w Polsce. Diabetol Prakt. 2007; 7: 8-15.
• 34. Hossain P, Kawar B, Nahas ME. Obesity and diabetes in the developing world – a growing challenge. N Engl J Med. 2007; 356: 213-215.
• 35. Colditz GA. Willet WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995; 122:481-486.
• 36. Koning L, Gerstein HC, Bosh J, et al. Anthropometric measures and glucose levels in a large multi-etnic cohort of individuals at risk of developing type 2 diabetes. Diabetologia 2010; 53: 1322-1328.
• 37. Mokdad AH, Ford ES, Bowman B, et al. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79.
• 38. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005; 146: 693-700.
• 39. Carral F, Olveira G, Aguilar M, et al. Hospital discharge records underreport the prevalence of diabetes in inpatients. Diabetes Res Clin Pract.2003; 59: 145-151.
• 40. Naslafkih A, Sestier F. Diabetes mellitus related morbidity, risk of hospitalization and disability. J Insurance Med. 2003; 35: 102-113.
• 41. Sasaki A. Mortality and causes of death in patients with diabetes mellitus in Japan. Diabetes Res Clin Pract. 1994; Suppl: S299-306.
• 42. Fu AZ, Qui Y, et al. Impact of concurrent macrovascular co-morbidities on healthcare utilization in patients with type 2 diabetes in Europe: amatches study. Diabetes Obes Metabol. 2010; 12: 631-637.
• 43. Bhansali A, Chattopatadhyay A, Dash RJ. Mortality in diabetes: a retrospective analysis from a tertiary care hospital in North India. Diabetes Res Clin Pract. 2003; 60: 119-124.
• 44. Jansson SP, Andersson DK, Svårdsudd K. Mortality trends in subjects with and without diabetes during 33 years of follow-up. Diabetes Care.2010; 33: 551-556.
• 45. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence and mortality in Ontario, Canada 1995-2005: a population-based study.Lancet. 2007; 369: 750-756.
• 46. Kinalska I, Niewiada M, Głogowski C, i in. Koszty cukrzycy typu 2 w Polsce (Badanie CODIP). Diabetologia Prakt. 2004; 5: 1-8.
• 47. Dall T, Mann SM, Zhang Y, et al. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008; 31: 596-615.
• 48. Pagano E, Bo S, Petrinco M, et al. Factors affecting hospitalization costs in Type 2 diabetes patients. J Diabetes Complic. 2009; 23: 1-6.
• 49. Łopatyński J, Mardarowicz G, Nicer T, et al. The prevalence of type II diabetes mellitus in rural urban population over 35 year of age inLublin region (Estern Poland). Pol Arch Med Wewn. 2001; 3: 781-786.
• 50. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperlipidemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocr Met. 2002; 87: 3978-3982.
• 51. Łagowska-Batyra A, Matuszek B, Lenart-Lipińska M, et al. Comparison of the course of type 2 diabetes in village and town inhabitants in theLublin region. Ann UMCS Lublin – Polonia 2010; 3: 69-77.
• 52. Polakowska M, Piotrowski W. Incidence of diabetes in the Polish population. Results of the multicenter Polish Population Health Status Study – WOBASZ. Arch Int Med. 2011; 5: 156-162.

Uwagi

rekord w opracowaniu